Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourLe CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Le CDC émet un avertissement de niveau 3 d'ici le 31 décembre ?
Oui
$117,078 Vol.
$117,078 Vol.
31 déc. 2026
Oui
$117,078 Vol.
$117,078 Vol.
31 déc. 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Volume
$117,078Date de fin
31 déc. 2026Marché ouvert
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$117,078Date de fin
31 déc. 2026Marché ouvert
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes